Pioglitazone lowers postload glucose and enhances composite insulin sensitivity index during oral glucose tolerance test compared with metformin or gliclazide in patients (pts) with Type 2 diabetes

被引：0
|
作者：
Tan, M
Johns, D
Ceriello, A
Widel, M
Gilmore, K
Eckland, D
机构：
[1] Eli Lilly & Co, Diabet Prod Team, Indianapolis, IN 46285 USA
[2] Univ Udine, Dept Pathol & Med, I-33100 Udine, Italy
[3] Takeda Europe, R&D Ctr Ltd, London, England
来源：
DIABETOLOGIA | 2004年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
718
引用
收藏
页码：A259 / A260
页数：2
相关论文
共 50 条
  • [21] Modeling the Shape of the Glucose Curve during an Oral Glucose Tolerance Test as a Risk Factor for Type 2 Diabetes
    Ha, Joon
    Sherman, Arthur
    Sumner, Anne
    Chung, Stephanie T.
    DIABETES, 2017, 66 : A582 - A582
  • [22] Pioglitazone enhances insulin sensitivity in patients with Type 2 diabetes mellitus.
    Pavo, I
    Herz, M
    Tan, M
    Shestakova, MV
    Smirnova, OM
    Jermendy, G
    Kerenyi, Z
    Widel, MH
    Schluchter, BJ
    Johns, D
    DIABETOLOGIA, 2002, 45 : A250 - A250
  • [23] Is fasting glucose level during oral glucose tolerance test an indicator of the insulin need in gestational diabetes?
    Akinci, Baris
    Celtik, Aygul
    Yener, Serkan
    Yesil, Sena
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2008, 82 (02) : 219 - 225
  • [24] Impact of insulin sensitivity and sets cell function on plasma glucose and insulin concentrations during an oral glucose tolerance test
    Martinez, DS
    Yoon, C
    Chiu, KC
    DIABETES, 2001, 50 : A517 - A517
  • [25] Relative contribution of insulin sensitivity and β-cell function to plasma glucose and insulin concentrations during the oral glucose tolerance test
    Chiu, KC
    Martinez, DS
    Yoon, C
    Chuang, LM
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2002, 51 (01): : 115 - 120
  • [26] Effect of pioglitazone and acarbose on endothelial inflammation biomarkers during oral glucose tolerance test in diabetic patients treated with sulphonylureas and metformin
    Derosa, G.
    Mereu, R.
    D'Angelo, A.
    Salvadeo, S. A.
    Ferrari, I.
    Fogari, E.
    Gravina, A.
    Palumbo, I.
    Maffioli, P.
    Randazzo, S.
    Cicero, A. F. G.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (05) : 565 - 579
  • [27] Impaired glucose tolerance with late hypersecretion of insulin during oral glucose tolerance test in patients with vasospastic angina
    Suzuki, U
    Nishizaki, M
    Arita, M
    Kakuta, T
    Numano, F
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1996, 27 (06) : 1458 - 1463
  • [28] Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokine in type 2 diabetic patients
    Miyazaki, Yoshinori
    Defronzo, Ralph A.
    DIABETES, 2008, 57 : A587 - A587
  • [29] Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients
    Miyazaki, Y.
    DeFronzo, R. A.
    DIABETES OBESITY & METABOLISM, 2008, 10 (12): : 1204 - 1211
  • [30] THE INSULIN SENSITIVITY INDEX CALCULATED FROM THE INTRAVENOUS GLUCOSE-TOLERANCE TEST ACCURATELY MEASURES INSULIN SENSITIVITY WHEN COMPARED WITH THE GLUCOSE CLAMP METHOD
    PACINI, G
    FINEGOOD, DT
    COBELLI, C
    BERGMAN, RN
    DIABETOLOGIA, 1983, 25 (02) : 185 - 185
12345